Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Utilization of nuclear structural proteins for targeted therapy and detection of proliferative and differentiation disorders

Utilization of nuclear structural proteins for targeted therapy and detection of proliferative and differentiation disorders

US Patent 6287790 · Granted Sep 11, 2001

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Macrotumor engineering2024
Ultrasonic device2023
Gradient-on-a-chip2021
Peptides, compositions, and methods for stimulating subcutaneous adipogenesis2020
Peptides that stimulate subcutaneous adipogenesis2020
Peptides that stimulate subcutaneous adipogenesis2019
Use of glycolytic pathways for inhibiting or measuring oncogenic signaling2017
Detecting and treating breast cancer resistance to EGFR inhibitors2016
Modulation of Rhamm (CD168) for selective adipose tissue development2014
Method of increasing radiation sensitivity by inhibition of beta one integrin2012
Drug screens based on the newly found role of dystroglycan proteolysis and resto2010
Method of increasing radiation sensitivity by inhibition of beta one integrin2009